Cellular Optimization & Genetic Insights

In under 6 minutes, each patient receives:

• A personalized health score
   
• Tailored system recommendations
   
• The mechanistic rationale behind each recommendation
   
• Links to peer-reviewed evidence
   
• Dosing and timing optimized using chronobiology and circadian science
   

All products are shipped directly to the patient for convenience and adherence.

APOA2

• Function: Lipid metabolism, response to saturated fat
   
• Health Category: Cardiovascular, Metabolic
   
• Clinical Applications: Hyperlipidemia, cardiovascular risk, obesity
   
• System Recommendation: Lipid-focused system, nutrigenomic lipid modulation
   

FTO

• Function: Energy balance, appetite regulation
   
• Health Category: Metabolic, Obesity, Cardiovascular
   
• Clinical Applications: Obesity, insulin resistance, type 2 diabetes, metabolic syndrome
   
• System Recommendation: Personalized metabolic system, chrono-nutrition timing
   

ADIPOQ

• Function: Adiponectin regulation, insulin sensitivity
   
• Health Category: Metabolic, Cardiovascular
   
• Clinical Applications: Type 2 diabetes, obesity, cardiovascular risk
   
• System Recommendation: Metabolic system with insulin sensitizers & mitochondrial support
   

CYP1A2

• Function: Caffeine & xenobiotic metabolism; oxidative stress
   
• Health Category: Cardiovascular, Neurological
   
• Clinical Applications: Hypertension, myocardial infarction risk, anxiety/insomnia, drug metabolism
   
• System Recommendation: Caffeine moderation, methylation support, antioxidant system
   

PPARD

• Function: Fatty acid oxidation, energy metabolism
   
• Health Category: Metabolic, Cardiovascular
   
• Clinical Applications: Dyslipidemia, insulin resistance, obesity, metabolic flexibility
   
• System Recommendation: Omega-3 & mitochondrial support system
   

ACTN3

• Function: Muscle fiber composition
   
• Health Category: Musculoskeletal, Fitness
   
• Clinical Applications: Sarcopenia, athletic performance, injury risk
   
• System Recommendation: Muscle support system (MyHMB®, creatine)
   

Note: These are examples. The full DNA panel includes 37 genes affecting metabolism, cardiovascular health, neurological function, hormonal balance, and fitness.
 

MTHFR

• Function: Folate → 5-methyl-THF
   
• Health Category: Cardiovascular, Neurological, Perimenopause
   
• Clinical Applications: ↑ Homocysteine, vascular inflammation, depression, menopause symptoms
   
• System Recommendation: 5-MTHF + methyl B12 + B6 system
   

COMT

• Function: Catecholamine & estrogen detox
   
• Health Category: Neurological, Hormonal, Perimenopause
   
• Clinical Applications: Anxiety, ADHD, estrogen dominance, menopause symptoms
   
• System Recommendation: B-vitamin & antioxidant system
   

VDR

• Function: Vitamin D receptor
   
• Health Category: Musculoskeletal, Immune
   
• Clinical Applications: Osteoporosis, immune dysregulation, muscle weakness
   
• System Recommendation: Vitamin D & mitochondrial system
   

BHMT

• Function: Alternative homocysteine remethylation pathway
   
• Health Category: Cardiovascular, Neurological
   
• Clinical Applications: Elevated homocysteine, methylation deficits
   
• System Recommendation: Methylation & betaine support system
   

CBS

• Function: Homocysteine breakdown
   
• Health Category: Cardiovascular, Neurological
   
• Clinical Applications: Oxidative stress, endothelial dysfunction, neurotoxicity
   
• System Recommendation: Antioxidant + methylation system
   

MTR

• Function: Homocysteine → methionine
   
• Health Category: Cardiovascular, Neurological
   
• Clinical Applications: DNA repair impairment, cardiovascular disease
   
• System Recommendation: Methylation system with B vitamins
   

MTRR

• Function: Regenerates MTR
   
• Health Category: Cardiovascular, Neurological, Hormonal
   
• Clinical Applications: Cardiovascular risk, homocysteine accumulation, methylation impairment
   
• System Recommendation: Methylcobalamin & methylation system support
   

Note: These are examples. The full methylation panel includes 16 genes, providing insight into methylation capacity, detoxification efficiency, neurotransmitter metabolism, and hormonal balance.
 

CYP1A2 is the main enzyme metabolizing ~95% of caffeine. Genetics influence fast or slow metabolizer phenotypes:

• Slow metabolizers (CYP1A2 C allele): Prolonged caffeine exposure, higher risk of hypertension, heart attack, anxiety, and sleep disturbances.
   
• Fast metabolizers (CYP1A2 AA allele): Faster caffeine clearance but increased oxidative stress, which can overwhelm methylation pathways (MTHFR, MTR, MTRR, COMT) if low-function alleles are present.
   

Clinical Insight: Personalized caffeine guidance, antioxidant support, and methylation systems are recommended to optimize metabolism and reduce cardiovascular and neurological risks.

• Preserves lean muscle mass via inhibition of the ubiquitin-proteasome pathway
   
• Improves recovery and functional independence
   
• Supports mTOR pathway for anabolic activity
   
• Relevant for adults 40+, injury recovery, and frailty prevention
   
• Evidence: Zhang et al., 2023; Meta-analysis, HMB in elderly populations
   

• Increases cellular energy availability, supporting muscle contraction and nutrient delivery
   
• Enhances vasodilation for blood flow and oxygenation
   
• Supports cognitive alertness indirectly via improved circulation
   
• Relevant for fatigue resistance, cognitive preservation, cardiovascular flow
   
• Evidence: Wilson et al., 2013; Purpura et al., 2017
   

• Neuroprotective: enhances ATP in brain cells, memory, cognition
   
• Supports muscle strength & bone density to reduce fall risk
   
• Improves glucose metabolism and insulin sensitivity
   
• Evidence: Hasselbalch et al., 2023
   

Synergy: Together, these systems combat muscle atrophy, restore cellular energy metabolism, reduce oxidative stress, and support mobility, performance, and independence.

Over 90,000 documented interactions, including:

• 30,000+ drug–nutrient depletions (e.g., statins depleting CoQ10)
   
• 20,000+ absorption conflicts (e.g., calcium impairing iron absorption)
   
• 10,000+ metabolic pathway competition (e.g., CYP450 interactions with folate)
   
• 30,000+ clinically observed adverse/synergistic effects
   

Databases referenced: Micromedex, Natural Medicines, FDA, NIH, EMA, PubMed, Lexicomp, DrugBank

Bottom Line: Clinicians cannot track all interactions manually—AI-enabled systems ensure precision, safety, and personalized optimization.

Every system is dosed and timed according to circadian rhythms to:

• Maximize absorption and efficacy
   
• Align with natural hormonal cycles
   
• Reduce side effects and oxidative stress
   
• Support mitochondrial and metabolic efficiency
   

✅ Summary:

• DNA panel and methylation panel provide insight into 37 and 16 genes, respectively.
   
• Systems address metabolism, methylation, cardiovascular, neurological, hormonal, musculoskeletal, and anti-aging health.
   
• Recommendations are personalized, science-driven, and optimized for timing, dosing, and delivery.
  
   

GLP-1 receptor agonists (semaglutide, tirzepatide class) alter glucose regulation, gastric emptying, appetite signaling, bile flow, and hepatic metabolism. That shift increases nutrient demand, modifies detox pathways, and can unmask latent genetic vulnerabilities — particularly within methylation and one-carbon metabolism.

Your 16-gene methylation panel evaluates the biochemical infrastructure that determines whether a patient will tolerate, adapt to, or struggle with GLP-1 therapy.

MTHFR, DHFR, MTR, MTRR, MAT1A, SHMT1, GNMT

These genes regulate folate activation, B12 recycling, SAMe synthesis, and DNA methylation capacity.

Why this matters for GLP-1:

• GLP-1 drugs commonly reduce appetite → lower dietary folate, B12, methionine intake
• Slower gastric emptying may impair B12 absorption
• Rapid fat loss increases oxidative stress and methyl demand
• Hepatic workload increases during lipolysis

If variants impair methylation efficiency:

• Homocysteine may rise
• Inflammation increases
• Fatigue, mood shifts, poor recovery appear
• Detox capacity declines

Without adequate methyl donors (5-MTHF, methyl-B12, betaine), GLP-1 therapy can expose subclinical insufficiencies.

BHMT, CBS

These regulate backup methylation pathways and sulfur/ammonia clearance.

Clinical relevance during GLP-1:

• Accelerated fat breakdown increases hepatic processing
• Impaired BHMT → reduced backup homocysteine clearance
• CBS variants → sulfur intolerance, headaches, irritability, detox overload

If these pathways are not supported, patients may report:

• Nausea beyond expected GLP-1 effect
• Brain fog
• Mood instability
• Poor tolerance at dose escalations

FMO1, PON1

These genes affect phase I metabolism and antioxidant defense.

GLP-1–induced fat loss releases stored lipophilic toxins. If detox capacity is genetically reduced:

• Chemical sensitivity increases
• Oxidative stress rises
• Inflammatory symptoms worsen
• Medication side effects intensify

Supporting glutathione production and antioxidant systems becomes critical.

COMT, VDR

GLP-1 impacts reward signaling and appetite centers in the brain. COMT variants alter dopamine breakdown. VDR affects immune and mood stability.

If COMT is slow:

• Higher sensitivity to stress
• Anxiety or overmethylation symptoms with aggressive methyl donor dosing
• Emotional flattening or irritability

If COMT is fast:

• Poor dopamine retention
• Fatigue or motivational drop during caloric deficit

Precision nutrient dosing prevents overshooting.

TCN2

Even with adequate intake, intracellular B12 delivery may be impaired.

GLP-1 slows gastric motility → increased risk of functional B12 deficiency.
In TCN2 variants, deficiency symptoms appear earlier and more aggressively.

Identify patients at risk for:

• Exaggerated nausea
• Mood dysregulation
• Fatigue
• Detox overload
• Homocysteine elevation

GLP-1 therapy increases demand for:

• Folate (active form)
• B12 (methyl or hydroxo depending on COMT status)
• B6 (P5P)
• Betaine
• Magnesium
• Choline

Blind supplementation creates risk. Gene-guided dosing removes guesswork.

By screening:

• You block predictable nutrient depletions
• You reduce interaction risk
• You document precision personalization
• You operate at clinical—not retail—standard

Optimized methylation improves:

• Fat loss efficiency
• Liver function
• Energy production
• Inflammation control
• Neurotransmitter stability

GLP-1 becomes a metabolic accelerator instead of a stressor